news | financial:
Synlab, XPhyto, Novavax - How long will the Corona boom last?
Read the whole article here:
https://t.co/2X9I6UYIT8
German version:
https://t.co/UzWeezaII7
$XPHY $XPHYF
XPhyto provides progress update on Psychedelic Medicine Programs and Novel Compounds Milestone
Press release available in English and German here:
https://t.co/Ns5PB8Tgul
$XPHY $XPHYF
news | financial:
Novavax, XPhyto Therapeutics, Biontech, Valneva - The vaccine blockbusters are on the move again!
Read the whole article here:
https://t.co/0guGxvO9Q9
$XPHY $XPHYF
"How XPhyto Therapeutics could revolutionise PCR Testing."
Read the article published by Health Europa in its latest issue of Health Europa Quarterly here:
https://t.co/cvPqMR6VCP
A German translation is available at:
https://t.co/KAN08f6fGe
$XPHY $XPHYF
XPhyto Executes Covid-ID Lab Sales Contracts with Test Clinics and Pharmacies in Germany as part of Multi-Product Rollout Strategy
Read the press release here:
https://t.co/YaiSwVxDL0
$XPHY $XPHYF
#CBD inhibits #COVID. Science article published last week:
https://t.co/pycveUa319
Inhibition of #SARS-CoV-2 replication is only possible when #THC is absent, so pure CBD is required.
#XPhyto is just ready to go for a first clinical study with Vektor's CBD-ODF.
$XPHY $XPHYF
"Fast PCR tests: Are they the solution?"
The Stuttgarter Zeitung presents under this headline rapid on-site #PCR tests as a possible solution for the emerging test shortage.
Read the article online (German, paid):
https://t.co/VFsGwmJ8UL
$XPHY $XPHYF
XPhyto Announces Head of Sales, Europe
Mr. Zdarek will focus on building out #distribution, #sales and #marketing, with high priority on the commercialization of Covid-ID Lab, the Company’s rapid RT-#PCR test.
Read the press release here:
https://t.co/MBEZgxIHmz
$XPHY $XPHYF
XPhyto signs Distribution Agreement for Czech Republic, rollout planned for Hungary, Slovakia, Ukraine and Russia
Read the press release here:
https://t.co/FGf26UYfn7
$XPHY $XPHYF
XPhyto Announces New Director of Business Development and Head of Diagnostic Research
Mr. Roland Spleiss joined as the Director of Business Development
Dr. Heinrich Jehle joined as Head of Diagnostic Research.
Read the press release here:
https://t.co/VsPOffvRY0
$XPHY $XPHYF
XPhyto #Epilepsy#clinicaltrial planned in 2022 with its proprietary fast-dissolving CBD oral strips
European human CBD bioavailability study will commence in January 2022.
https://t.co/wQCDRZAIzA
$XPHY $XPHYF
XPhyto Completes Strategic #Acquisition of 3a-diagnostics
- Positioned as leading #Biosensor producer
- Adds IP and scientific expertise
- Gains technical and business synergies
- Secures #infectious#disease biosensor portfolio
https://t.co/WTIA0qunHH
$XPHY $XPHYF
We’re leading ground-breaking work in pharmaceuticals.
From applying psychedelics to major neurological diseases to developing rapid testing to support pandemic management; our work is all about innovation to impact.
Learn more about us here: https://t.co/QVJ16TABqR
$XPHY
As more people start to see the potential of psychedelics as a treatment for severe mental health concerns, investment in the innovative companies at the forefront continues to surge.
Read the full @EPM_Magazine article here: https://t.co/vI98zX3j9d
$XPHY